Early triage of critically ill COVID-19 patients using deep learning.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
15 07 2020
Historique:
received: 16 04 2020
accepted: 12 06 2020
entrez: 17 7 2020
pubmed: 17 7 2020
medline: 28 7 2020
Statut: epublish

Résumé

The sudden deterioration of patients with novel coronavirus disease 2019 (COVID-19) into critical illness is of major concern. It is imperative to identify these patients early. We show that a deep learning-based survival model can predict the risk of COVID-19 patients developing critical illness based on clinical characteristics at admission. We develop this model using a cohort of 1590 patients from 575 medical centers, with internal validation performance of concordance index 0.894 We further validate the model on three separate cohorts from Wuhan, Hubei and Guangdong provinces consisting of 1393 patients with concordance indexes of 0.890, 0.852 and 0.967 respectively. This model is used to create an online calculation tool designed for patient triage at admission to identify patients at risk of severe illness, ensuring that patients at greatest risk of severe illness receive appropriate care as early as possible and allow for effective allocation of health resources.

Identifiants

pubmed: 32669540
doi: 10.1038/s41467-020-17280-8
pii: 10.1038/s41467-020-17280-8
pmc: PMC7363899
doi:

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3543

Commentaires et corrections

Type : CommentIn

Références

JAMA. 2003 Jun 4;289(21):2801-9
pubmed: 12734147
Nat Med. 2019 Aug;25(8):1301-1309
pubmed: 31308507
Nature. 2017 Jun 28;546(7660):686
pubmed: 28658222
J Pathol. 2004 Jun;203(2):631-7
pubmed: 15141377
Lancet Oncol. 2020 Mar;21(3):335-337
pubmed: 32066541
Eur Respir J. 2020 May 14;55(5):
pubmed: 32217650
BMC Med Res Methodol. 2018 Feb 26;18(1):24
pubmed: 29482517
J Stat Softw. 2011 Mar;39(5):1-13
pubmed: 27065756
JAMA. 2020 Apr 7;323(13):1239-1242
pubmed: 32091533
Nature. 2020 Mar;579(7798):270-273
pubmed: 32015507
Nature. 2015 May 28;521(7553):436-44
pubmed: 26017442
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
J Clin Oncol. 2008 Mar 10;26(8):1364-70
pubmed: 18323559
Thorax. 1996 Oct;51(10):1010-6
pubmed: 8977602

Auteurs

Wenhua Liang (W)

China State Key Laboratory of Respiratory Disease and National Clinical Research Center for Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.

Jianhua Yao (J)

Tencent AI Lab, Shenzhen, China.

Ailan Chen (A)

China State Key Laboratory of Respiratory Disease and National Clinical Research Center for Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Hankou Hospital, Wuhan, China.

Qingquan Lv (Q)

Hankou Hospital, Wuhan, China.

Mark Zanin (M)

School of Public Health, The University of Hong Kong, Hong Kong SAR, China.

Jun Liu (J)

China State Key Laboratory of Respiratory Disease and National Clinical Research Center for Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Department of Thoracic Surgery, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.

SookSan Wong (S)

China State Key Laboratory of Respiratory Disease and National Clinical Research Center for Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.

Yimin Li (Y)

Department of Intensive Care Unit, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.

Jiatao Lu (J)

Hankou Hospital, Wuhan, China.

Hengrui Liang (H)

China State Key Laboratory of Respiratory Disease and National Clinical Research Center for Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Department of Thoracic Surgery, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.

Guoqiang Chen (G)

Foshan Hospital, Foshan, China.

Haiyan Guo (H)

Foshan Hospital, Foshan, China.

Jun Guo (J)

Daye Hospital, Hubei, China.

Rong Zhou (R)

China State Key Laboratory of Respiratory Disease and National Clinical Research Center for Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.

Limin Ou (L)

China State Key Laboratory of Respiratory Disease and National Clinical Research Center for Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.

Niyun Zhou (N)

Tencent AI Lab, Shenzhen, China.

Hanbo Chen (H)

Tencent AI Lab, Shenzhen, China.

Fan Yang (F)

Tencent AI Lab, Shenzhen, China.

Xiao Han (X)

Tencent AI Lab, Shenzhen, China.

Wenjing Huan (W)

Tencent Healthcare, Shenzhen, China.

Weimin Tang (W)

Tencent Healthcare, Shenzhen, China.

Weijie Guan (W)

China State Key Laboratory of Respiratory Disease and National Clinical Research Center for Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.

Zisheng Chen (Z)

China State Key Laboratory of Respiratory Disease and National Clinical Research Center for Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Department of Respiratory Disease, The Sixth Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.

Yi Zhao (Y)

China State Key Laboratory of Respiratory Disease and National Clinical Research Center for Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.

Ling Sang (L)

China State Key Laboratory of Respiratory Disease and National Clinical Research Center for Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.

Yuanda Xu (Y)

Department of Intensive Care Unit, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.

Wei Wang (W)

Department of Thoracic Surgery, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.

Shiyue Li (S)

China State Key Laboratory of Respiratory Disease and National Clinical Research Center for Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.

Ligong Lu (L)

Zhuhai People Hospital, Zhuhai, China.

Nuofu Zhang (N)

China State Key Laboratory of Respiratory Disease and National Clinical Research Center for Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.

Nanshan Zhong (N)

China State Key Laboratory of Respiratory Disease and National Clinical Research Center for Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China. nanshan@vip.163.com.

Junzhou Huang (J)

Tencent AI Lab, Shenzhen, China. joehhuang@tencent.com.

Jianxing He (J)

China State Key Laboratory of Respiratory Disease and National Clinical Research Center for Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China. drjianxing.he@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH